Latest TriLink Biotechnologies Inc. Stories
Agreement strengthens New England Biolabs' position as a key supplier to the RNA synthesis sector IPSWICH, Mass., Oct. 7, 2014 /PRNewswire/ -- New England Biolabs, Inc.
SAN DIEGO, July 28, 2011 /PRNewswire/ -- TriLink BioTechnologies, Inc.
SAN DIEGO, May 27, 2011 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink), a leader in manufacturing high quality oligonucleotides and nucleoside triphosphates, announced today the award of their CleanAmp(TM) Primer patent by the European Patent Office (EPO Patent no. 2032714).
SAN DIEGO, March 28, 2011 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink) announced that it has entered into a distribution agreement with TATAA Biocenter (TATAA) to sell its CleanAmp(TM) Products.
SAN DIEGO, March 15, 2011 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink) was recently awarded a Phase I SBIR Grant of approximately $100,000 by the National Institutes of Health to develop a Hot Start approach for Ligase Chain Reaction (LCR).
SAN DIEGO, Dec. 16, 2010 /PRNewswire/ -- TriLink BioTechnologies (TriLink), a leading provider of custom nucleic acid-based products, today announced the launch of an innovative Hot Start solution for the PCR amplification of problematic GC-rich sequences, CleanAmp(TM) 7-deaza-dGTP.
SAN DIEGO, Nov. 1, 2010 /PRNewswire/ -- TriLink BioTechnologies (TriLink) today announced that they have formed a team that will participate in this fall's Light The NightÂ® Walk, raising money to find cures for cancer and provide critical support to patients and their families.
- The act of sweetening by admixture of some saccharine substance.